Silicon Valley-based Intabio Inc, a provider of an analytical platform for the development of biotherapeutic drugs, has raised $9.5 million in Series A financing. Northpond Ventures led the round with participation from other investors that included Genoa Ventures and Vertical Venture Partners.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: